Literature DB >> 15162549

Effects of mu and kappa opioid receptor agonists and antagonists on contraction of isolated colon strips of rats with cathartic colon.

Bao-Hua Liu1, Ping Mo, Sheng-Ben Zhang.   

Abstract

AIM: To study the effects of mu and kappa opioid receptor agonists and antagonists on the isolated colon strips of rats with cathartic colon.
METHODS: Cathartic colon model was established by feeding rats with contact laxatives, and effects of mu and kappa opioid receptor agonists and antagonists on electricity-stimulated contraction of isolated colon strips of rats with cathartic colon were observed.
RESULTS: Compared with control group, exogenous mu and kappa agonists inhibited significantly electricity-stimulated contraction of strips of cathartic colon (8.50+/-0.89 mm, 6.24+/-0.91 mm, 3.35+/-0.6 mm vs 11.40+/-0.21 mm P<0.01; 8.98+/-0.69 mm, 6.89+/-0.71 mm, 4.43+/-0.99 mm vs 11.40+/-0.21 mm, P<0.01). In contrast, the exogenous mu antagonist significantly enhanced electricity-stimulated contraction of isolated colon strips (13.18+/-0.93 mm, 15.87+/-0.98 mm, 19.46+/-1.79 mm vs 11.40+/-0.21 mm, P<0.01), but kappa antagonist had no effect on the isolated colon strips of rats with cathartic colon.
CONCLUSION: Mu and kappa opioid receptors are involved in the regulation of colon motility of rats with cathartic colon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162549      PMCID: PMC4572778          DOI: 10.3748/wjg.v10.i11.1672

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

Review 1.  Conformation-activity relationships of opioid peptides with selective activities at opioid receptors.

Authors:  V J Hruby; R S Agnes
Journal:  Biopolymers       Date:  1999       Impact factor: 2.505

2.  Distribution of enkephalin-like immunoreactivity in the cat digestive tract.

Authors:  D Bagnol; M Henry; A Cupo; Y Julé
Journal:  J Auton Nerv Syst       Date:  1997-05-12

Review 3.  [Opioid receptor knockout mice].

Authors:  I Sora
Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi       Date:  1999-12

4.  Low-dose oral naloxone reverses opioid-induced constipation and analgesia.

Authors:  Maywin Liu; Eric Wittbrodt
Journal:  J Pain Symptom Manage       Date:  2002-01       Impact factor: 3.612

Review 5.  Management of the irritable bowel syndrome.

Authors:  M Camilleri
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

6.  Effects of kappa opioids in the inflamed rat colon.

Authors:  J N Sengupta; A Snider; X Su; G F Gebhart
Journal:  Pain       Date:  1999-02       Impact factor: 6.961

7.  Development of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in mice.

Authors:  Koichi Tan-No; Fukie Niijima; Osamu Nakagawasai; Takumi Sato; Susumu Satoh; Takeshi Tadano
Journal:  Eur J Pharm Sci       Date:  2003-11       Impact factor: 4.384

8.  Role of opiate receptors in the regulation of colonic transit.

Authors:  P N Kaufman; B Krevsky; L S Malmud; A H Maurer; M B Somers; J A Siegel; R S Fisher
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

Review 9.  Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds.

Authors:  Michael J Callahan
Journal:  J Clin Gastroenterol       Date:  2002-07       Impact factor: 3.062

  9 in total
  5 in total

1.  Effects of nociceptin/orphanin FQ on rats with cathartic colon.

Authors:  Hai-Yan Li; Xiang Yan; Quan-Lai Xue; Yong-Ning Zhou; Yan Gao; Rui Wang; Yong-Ming Liu; Jun-Tao Ran
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.

Authors:  D Philippe; D Chakass; X Thuru; P Zerbib; A Tsicopoulos; K Geboes; P Bulois; M Breisse; H Vorng; J Gay; J-F Colombel; P Desreumaux; M Chamaillard
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

3.  Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.

Authors:  Marta Zielińska; Agata Jarmuż; Andrzej Wasilewski; Gerta Cami-Kobeci; Stephen Husbands; Jakub Fichna
Journal:  Pharmacol Rep       Date:  2016-12-05       Impact factor: 3.024

4.  Opioid receptors and associated regulator of G protein signaling are involved in the cathartic colon of rats.

Authors:  Jinsong Wu; Baohua Liu; Weidong Tong; Anping Zhang; Fan Li; Jing Lin; L I Wang
Journal:  Exp Ther Med       Date:  2015-01-29       Impact factor: 2.447

Review 5.  Animal models of cathartic colon.

Authors:  Yang-Yang Meng; Qiao-Dong Li; Ya Feng; Jie Liu; En-Kang Wang; Linda Zhong; Qiao-Li Sun; Jian-Ye Yuan
Journal:  World J Clin Cases       Date:  2021-02-26       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.